Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein
Authors:
- 1 September 2014
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1842 (9) , 1350-1363
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81300716)
- Specialized Research Fund for the Doctoral Program of Higher Education (20120201120089)
- Scientific Research Fund of Shaanxi Provincial Department of Health (2012D59)
This publication has 39 references indexed in Scilit:
- The Multifaceted Actions of PTHrP in Skeletal MetastasisFuture Oncology, 2012
- Genes associate with abnormal bone cell activity in bone metastasisCancer and Metastasis Reviews, 2012
- Therapeutic Strategies to Target TGF-β in the Treatment of Bone MetastasesCurrent Pharmaceutical Biotechnology, 2011
- Immune regulation of the tumor/bone vicious cycleAnnals of the New York Academy of Sciences, 2011
- PTHrP Induces Autocrine/Paracrine Proliferation of Bone Tumor Cells through Inhibition of ApoptosisPLOS ONE, 2011
- TGF-β in cancer and bone: Implications for treatment of bone metastasesBone, 2011
- The critical role of the bone microenvironment in cancer metastasesMolecular and Cellular Endocrinology, 2009
- International epidemiology of prostate cancer: Geographical distribution and secular trendsMolecular Nutrition & Food Research, 2009
- Tumor expressed PTHrP facilitates prostate cancer‐induced osteoblastic lesionsInternational Journal of Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008